{"nctId":"NCT01343082","briefTitle":"DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension","startDateStruct":{"date":"2011-05"},"conditions":["Open Angle Glaucoma or Ocular Hypertension"],"count":148,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: DE-111 ophthalmic solution"]}],"interventions":[{"name":"DE-111 ophthalmic solution","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosed with open angle glaucoma or ocular hypertension\n* Provided signed, written informed consent\n* 20 years of age and older\n* If a subject is a female of childbearing potential, she must utilize reliable contraceptive throughout the study, and must have a negative urine pregnancy test prior to enrollment into this study\n\nExclusion Criteria:\n\n* Females who are pregnant, nursing or planning a pregnancy, or females of childbearing potential who are not using a reliable method of contraception.\n* Presence of any abnormality or significant illness that could be expected to interfere with the study.","sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in IOP (Intraocular Pressure) at End of Study","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.8","spread":"2.2"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":136},"commonTop":["Growth of eyelashes","Nasopharyngitis","Punctate keratitis","Conjunctival hyperaemia","Blepharal pigmentation"]}}}